CD4 and cryptococcosis: In a study conducted by Singh et al. [21], fluconazole (200 mg thrice weekly) given to HIV-infected patients with CD4 cell counts of lower than or equal to 100/mm3 was efficacious as primary prophylaxis for cryptococcosis, with notably lower costs and increased convenience for patients in comparison with daily administration of the drug, in the pre-ART era.